The top 5 policy announcements from July 2019
From new updates on the Zika virus to the approval of a sexual dysfunction treatment, these were the top policy updates in July.
_4.jpg?w=1500&fit=max&auto=format)
CDC releases ‘benchmark’ data on pelvic exams
The CDC released a new analysis that may be a benchmark for women’s behavior regarding pelvic exams before ACOG made a sea change in guidance on when to perform the tests.
Read more: CDC releases ‘benchmark’ data on pelvic exams
©EtiAmmos/shutterstock.com
.jpeg?w=1500&fit=max&auto=format)
Sexual dysfunction treatment approved by FDA
Bremelanotide is an injectable indicated for premenopausal women with hypoactive sexual desire disorder (HSDD).
Read more: Sexual dysfunction treatment approved by FDA
©Olivier Le Moal - stock.adobe.com
.jpeg?w=1500&fit=max&auto=format)
Updated FDA advice for women on eating fish
The FDA suggests that American women are not eating enough fish, though consumers still need to be mindful of which fish to avoid.
Read more: Updated FDA advice for women on eating fish
©Jacek Chabraszewski - stock.adobe.com
_2.jpeg?w=1500&fit=max&auto=format)
ACC/AHA guidelines for identifying gestational hypertension
A recent study examined whether using an expanded definition for hypertension would result in better identification of women at risk for gestational hypertension.
Read more: ACC/AHA guidelines for identifying gestational hypertension
©didesign - stock.adobe.com
_1.jpeg?w=1500&fit=max&auto=format)
WHO issues new Zika updates
The World Health Organization (WHO) released two Zika virus (ZIKV)-related updates, one on epidemiology and the other with information for travelers.
Read more: WHO issues new Zika updates
©Feng Yu -stock.adobe.com